| UPSA Switzerland AG - Co-Dafalgan, Filmtabletten |
| 51321 | | 01 | | Co-Dafalgan | | Filmtabletten | | N02AJ06 | | Codeine and Paracetamol | | 19.04.1993 | | |
|
| Composition |
| paracetamolum 500 mg, codeini phosphas hemihydricus 30 mg, povidonum, cellulosum microcristallinum, carmellosum natricum conexum, magnesii stearas, Überzug: hypromellosum, propylenglycolum, E 171 pro compresso obducto corresp. natrium 2.1 mg. |
| Packungsbestandteile |
| Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Codeine Phosphate Hemihydrate | 30 mg | | Paracetamole | 500 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Codeine Phosphate Hemihydrate | 30 mg | | Paracetamole | 500 mg |
| | | | Agents auxilliaires | | informations additionels |
|---|
| Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | Hypromellosum | | Überzug | | Magnesii Stearas | | | | Povidone | | | | Pro Compresso Obducto | | | | Propylenglycol | | |
| |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 014 | 16 Comprimé(s) | 1.85 | 11.25 | B | LS | Non | | 022 | 40 Comprimé(s) | 4.40 | 14.00 | B | LS | Non |
|
